This reiterates the need for combination therapy, as it confirms that in addition to TBI therapy you also need to adoptively transfer tumor-specific CD8 T cells to induce an effective anti-tumor immune response that prevents tumor escape. This evidence concerns the gene CD8A and neoplasm.